$CODX
Co-Diagnostics Inc

2022 Q1 Form 10-Q Financial Statement

#000149315222013020 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1
Revenue $22.70M
YoY Change 13.38%
Cost Of Revenue $3.282M
YoY Change 0.37%
Gross Profit $19.42M
YoY Change 15.92%
Gross Profit Margin 85.54%
Selling, General & Admin $5.574M
YoY Change 34.97%
% of Gross Profit 28.71%
Research & Development $3.771M
YoY Change 69.88%
% of Gross Profit 19.42%
Depreciation & Amortization $247.3K
YoY Change 253.23%
% of Gross Profit 1.27%
Operating Expenses $9.593M
YoY Change 49.42%
Operating Profit $9.824M
YoY Change -4.9%
Interest Expense -$9.950K
YoY Change -97.79%
% of Operating Profit -0.1%
Other Income/Expense, Net $3.277M
YoY Change
Pretax Income $13.10M
YoY Change 32.6%
Income Tax $1.386M
% Of Pretax Income 10.58%
Net Earnings $11.71M
YoY Change 48.31%
Net Earnings / Revenue 51.61%
Basic Earnings Per Share $0.35
Diluted Earnings Per Share $337.5K
COMMON SHARES
Basic Shares Outstanding 33.94M shares
Diluted Shares Outstanding 34.71M shares

Balance Sheet

Concept 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $97.42M
YoY Change 62.13%
Cash & Equivalents $97.42M
Short-Term Investments $0.00
Other Short-Term Assets $1.354M
YoY Change 88.0%
Inventory $4.901M
Prepaid Expenses
Receivables $21.66M
Other Receivables $0.00
Total Short-Term Assets $125.3M
YoY Change 58.4%
LONG-TERM ASSETS
Property, Plant & Equipment $2.858M
YoY Change 180.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $983.6K
YoY Change 2.46%
Other Assets
YoY Change
Total Long-Term Assets $45.81M
YoY Change 2202.16%
TOTAL ASSETS
Total Short-Term Assets $125.3M
Total Long-Term Assets $45.81M
Total Assets $171.2M
YoY Change 110.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.215M
YoY Change 81.35%
Accrued Expenses $2.897M
YoY Change 69.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.02M
YoY Change 202.1%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $4.548M
YoY Change 726.84%
Total Long-Term Liabilities $4.548M
YoY Change 726.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.02M
Total Long-Term Liabilities $4.548M
Total Liabilities $23.44M
YoY Change 382.24%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $147.7M
YoY Change
Total Liabilities & Shareholders Equity $171.2M
YoY Change 110.99%

Cashflow Statement

Concept 2022 Q1
OPERATING ACTIVITIES
Net Income $11.71M
YoY Change 48.31%
Depreciation, Depletion And Amortization $247.3K
YoY Change 253.23%
Cash From Operating Activities $7.806M
YoY Change -36.38%
INVESTING ACTIVITIES
Capital Expenditures -$396.6K
YoY Change 183.29%
Acquisitions
YoY Change
Other Investing Activities $1.255M
YoY Change -50.38%
Cash From Investing Activities $858.7K
YoY Change -64.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 150.0K
YoY Change 0.0%
NET CHANGE
Cash From Operating Activities 7.806M
Cash From Investing Activities 858.7K
Cash From Financing Activities 150.0K
Net Change In Cash 8.815M
YoY Change -40.48%
FREE CASH FLOW
Cash From Operating Activities $7.806M
Capital Expenditures -$396.6K
Free Cash Flow $8.202M
YoY Change -33.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
CY2021Q1 CODX Noncash Or Part Noncash Inventory Moved To Property Plant And Equipment
NoncashOrPartNoncashInventoryMovedToPropertyPlantAndEquipment
USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2022Q1 CODX Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022Q1 CODX Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
shares
CY2022Q1 CODX Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q1 CODX Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Non Options Expirations Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsExpirationsWeightedAverageGrantDateFairValue
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
shares
CY2022Q1 CODX Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022Q1 CODX Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Non Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsForfeitedWeightedAverageGrantDateFairValue
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
USD
CY2022Q1 CODX Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
USD
CY2022Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
USD
CY2021Q1 CODX Gain On Remeasurement Of Acquisition Contingencies
GainOnRemeasurementOfAcquisitionContingencies
USD
CY2021Q1 CODX Gain On Remeasurement Of Acquisition Contingencies
GainOnRemeasurementOfAcquisitionContingencies
USD
CY2021Q1 CODX Noncash Lease Expense
NoncashLeaseExpense
USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
USD
CY2022Q1 CODX Payments To Acquire Interest In Joint Ventures
PaymentsToAcquireInterestInJointVentures
USD

Files In Submission

Name View Source Status
0001493152-22-013020-index-headers.html Edgar Link pending
0001493152-22-013020-index.html Edgar Link pending
0001493152-22-013020.txt Edgar Link pending
0001493152-22-013020-xbrl.zip Edgar Link pending
codx-20220331.xsd Edgar Link pending
codx-20220331_cal.xml Edgar Link unprocessable
codx-20220331_def.xml Edgar Link unprocessable
codx-20220331_lab.xml Edgar Link unprocessable
codx-20220331_pre.xml Edgar Link unprocessable
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending